Agency Information Collection Activities: Proposed Collection; Comment Request, 80820-80821 [2010-32197]
Download as PDF
<![CDATA[
mstockstill on DSKH9S0YB1PROD with NOTICES
80820
Federal Register / Vol. 75, No. 246 / Thursday, December 23, 2010 / Notices
the approximate time requested for the
presentation. Oral comments made at
the public meeting must also be
submitted to the NIOSH Docket Office
in writing in order to be considered by
the Agency.
Request for Information: NIOSH seeks
to obtain materials, including published
and unpublished reports and research
findings, to evaluate the possible health
risks of occupational exposure to carbon
nanotubes and nanofibers. Examples of
requested information include, but are
not to be limited to:
(1) Identification of industries or
occupations in which exposures to
carbon nanotubes and nanofibers can
occur;
(2) Trends in the production and use
of carbon nanotubes and nanofibers;
(3) Exposure measurement data;
(4) Case reports or other health
information demonstrating possible
health effects in workers exposed to
carbon nanotubes or nanofibers;
(5) Reports of experimental in vivo
and in vitro studies that provide
evidence of a dose-relationship between
exposure to carbon nanotubes and
nanofibers and biological activity;
(6) Reports of experimental data on
the airborne characteristics of carbon
nanotubes or nanofibers, including
information on the amounts that are
inhalable and respirable;
(7) Criteria and rationale for including
workers in a medical surveillance and
screening program;
(8) Description of work practices and
engineering controls used to reduce or
prevent workplace exposure to carbon
nanotubes and nanofibers; and
(9) Educational materials for worker
safety and training on the safe handling
of carbon nanotubes and nanofibers.
ADDRESSES: Written comments or
requests to attend or present at the
meeting, identified by docket number
NIOSH–161–A, may be submitted by
any of the following ways:
• Mail: NIOSH Docket Office, Robert
A. Taft Laboratories, MS–C34, 4676
Columbia Parkway, Cincinnati, OH
45226.
• Facsimile: (513) 533–8285.
• E-mail: nioshdocket@cdc.gov.
All information received in response
to this notice will be available for public
examination and copying at the NIOSH
Docket Office, 4676 Columbia Parkway,
Room 111, Cincinnati, OH 45226. A
complete electronic docket containing
all comments submitted will be
available on the NIOSH Web page at
https://www.cdc.gov/niosh/docket, and
comments will be available in writing
by request. NIOSH includes all
comments received without change in
VerDate Mar<15>2010
18:06 Dec 22, 2010
Jkt 223001
the docket, including any personal
information provided. All electronic
comments should be formatted as
Microsoft Word. Please make reference
to docket number NIOSH 161–A.
FOR FURTHER INFORMATION CONTACT:
Ralph D. Zumwalde, NIOSH, Robert A.
Taft Laboratories MS–C32, 4676
Columbia Parkway, Cincinnati, OH
45226, telephone (513) 533–8320.
Dated: December 13, 2010.
Tanja Popovic,
Deputy Associate Director for Science,
Centers for Disease Control and Prevention.
[FR Doc. 2010–32328 Filed 12–22–10; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–R–153]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS), Department of Health
and Human Services, is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the Agency’s function;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Reinstatement with change of a
previously approved collection; Title of
Information Collection: Medicaid Drug
Utilization Review (DUR) Annual
Report; Use: The DUR program is
required to assure that prescriptions are
appropriate, medically necessary and
are not likely to result in adverse
medical results. Each State DUR
program must consist of prospective
drug use review, retrospective drug use
review, data assessment of drug use
AGENCY:
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
against predetermined standards, and
ongoing educational outreach activities.
In addition, States are required to
submit an annual DUR program report
that includes a description of the nature
and scope of State DUR activities. Over
the years, technology has changed as
has the practice of the pharmacy.
Therefore, CMS has revised the old
survey vehicle to more fully address the
current practices and areas of concern
with the Medicaid Pharmacy Programs.
Form Number: CMS–R–153 (OMB#:
0938–0659); Frequency: Annually;
Affected Public: State, Local, or Tribal
Governments; Number of Respondents:
51; Total Annual Responses: 51; Total
Annual Hours: 20,298. (For policy
questions regarding this collection
contact Madlyn Kruh at 410–786–3239.
For all other issues call 410–786–1326.)
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS Web site
address at https://www.cms.hhs.gov/
PaperworkReductionActof1995,
or e-mail your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
To be assured consideration,
comments and recommendations for the
proposed information collections must
be received by the OMB desk officer at
the address below, no later than 5 p.m.
on January 24, 2011: OMB, Office of
Information and Regulatory Affairs,
Attention: CMS Desk Officer. Fax
Number: (202) 395–6974. E-mail:
OIRA_submission@omb.eop.gov.
Dated: December 17, 2010.
Martique Jones,
Director, Regulations Development
Division-B, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2010–32196 Filed 12–22–10; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier CMS–10367]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
AGENCY:
E:\FR\FM\23DEN1.SGM
23DEN1
mstockstill on DSKH9S0YB1PROD with NOTICES
Federal Register / Vol. 75, No. 246 / Thursday, December 23, 2010 / Notices
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: New collection (Request for a
new OMB Control Number); Title of
Information Collection: Medicaid State
Plan Preprint for Use by States When
Implementing Section 6505 of the
[Patient Protection and] Affordable Care
Act; Use: [The] CMS has developed a
Medicaid State Plan Preprint for use by
States and specific to support the
January 1, 2011, mandate of the
prohibition on payments outside of the
United States. The Preprint follows the
format and requested information from
prior preprints provided to the States by
CMS and provides a placeholder and
assurance of compliance with section
1902(a) of the Social Security Act; Form
Number: CMS–10367 (OMB#: 0938–
NEW); Frequency: Occasionally;
Affected Public: State, Local, or Tribal
Governments; Number of Respondents:
56; Total Annual Responses: 56; Total
Annual Hours: 5. (For policy questions
regarding this collection contact Carla
Ausby at 410–786–2153. For all other
issues call 410–786–1326.)
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS’ Web site
at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
In commenting on the proposed
information collections please reference
the document identifier or OMB control
number. To be assured consideration,
comments and recommendations must
be submitted in one of the following
ways by February 22, 2011:
1. Electronically. You may submit
your comments electronically to https://
www.regulations.gov. Follow the
VerDate Mar<15>2010
18:06 Dec 22, 2010
Jkt 223001
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) accepting comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number, Room C4–26–05, 7500
Security Boulevard, Baltimore,
Maryland 21244–1850.
Dated: December 17, 2010.
Martique Jones,
Director, Regulations Development DivisionB, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2010–32197 Filed 12–22–10; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–N–0266]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Study of Clinical
Efficacy Information in Professional
Labeling and Direct-to-Consumer Print
Advertisements for Prescription
Drugs; Correction
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; correction.
The Food and Drug
Administration (FDA) is correcting a
notice that appeared in the Federal
Register of December 3, 2010 (75 FR
75477). The document announced a
proposed collection of information that
has been submitted to the Office of
Management and Budget (OMB) for
review and clearance under the
Paperwork Reduction Act of 1995 (the
PRA). The document was published
with an error. FDA, upon further
review, realized that 3 comments had
been submitted in response to the 60day notice and the responses to those
comments are included in this notice.
This document corrects that error.
FOR FURTHER INFORMATION CONTACT:
Elizabeth Berbakos, Office of
Information Management, Food and
Drug Administration, 1350 Piccard Dr.,
PI50–400B, Rockville, MD 20850, 301–
796–3792,
Elizabeth.Berbakos@fda.hhs.gov.
SUMMARY:
In FR Doc.
2010–30385, appearing on page 75480,
in the Federal Register of Friday,
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
80821
December 3, 2010, the following
correction is made:
On page 75480, in the third column,
the last sentence in the sixth complete
paragraph states that no comments were
received on the paperwork burden for
the 60-day notice that published in the
Federal Register of June 16, 2010 (75 FR
34142). FDA is correcting that statement
to read: Three comments were received
that expressed support for the research
and recommended minor improvements
to the study. The responses to those
comments are included in the following
paragraphs.
(Comment 1) Several of this
comment’s suggestions have already
been incorporated into our study design.
Specifically, we agree that the study
design should include the variables of
age, education, ethnicity, race, health
literacy, and whether the respondent is
currently being treated with a
prescription drug, and have included
them in the questionnaire. Also, we
have contracted with an organization
that produces realistic ads and stimuli
to ensure that we will show respondents
realistic materials.
Another question from this comment
was the presentation of our
manipulations. To clarify, the specific
format of the presentation will be text
only. We are investigating the use of
charts and other visuals in another
study (FDA–2009–N–0263 (January 5,
2010), ‘‘Presentation of Quantitative
Effectiveness and Risk Information to
Consumers in Direct-to-Consumer (DTC)
Broadcast and Print Advertisements for
Prescription Drugs,’’ OMB control
number 0910–0663.) Because all of the
respondents in the current study will
see the information in the same format,
this will not compromise our ability to
answer the current research questions.
The comment also recommends
expanding the physician study to
include all health care professionals
who have the ability to prescribe (i.e.,
nurse practitioners and physician
assistants). This is a good idea, but it
changes our research question from how
physicians use labels to how prescribers
use labels. These groups vary in
education and may vary in experience
and training in how to interpret and use
clinical trial data. Because we do not
have a sample size that is large enough
to analyze differences between these
groups, we will limit the sample to
physicians in this study.
Finally, the comment recommends
that FDA publish findings from the
preliminary study related to the current
project, ‘‘Mental Models Study of Health
Care Providers’ Understanding of
Prescription Drug Effectiveness’’ (FDA–
2008–N–0589; April 3, 2009). We agree
E:\FR\FM\23DEN1.SGM
23DEN1
]]>Agencies
[Federal Register Volume 75, Number 246 (Thursday, December 23, 2010)]
[Notices]
[Pages 80820-80821]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-32197]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier CMS-10367]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, HHS.
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
[[Page 80821]]
Centers for Medicare & Medicaid Services (CMS) is publishing the
following summary of proposed collections for public comment.
Interested persons are invited to send comments regarding this burden
estimate or any other aspect of this collection of information,
including any of the following subjects: (1) The necessity and utility
of the proposed information collection for the proper performance of
the agency's functions; (2) the accuracy of the estimated burden; (3)
ways to enhance the quality, utility, and clarity of the information to
be collected; and (4) the use of automated collection techniques or
other forms of information technology to minimize the information
collection burden.
1. Type of Information Collection Request: New collection (Request
for a new OMB Control Number); Title of Information Collection:
Medicaid State Plan Preprint for Use by States When Implementing
Section 6505 of the [Patient Protection and] Affordable Care Act; Use:
[The] CMS has developed a Medicaid State Plan Preprint for use by
States and specific to support the January 1, 2011, mandate of the
prohibition on payments outside of the United States. The Preprint
follows the format and requested information from prior preprints
provided to the States by CMS and provides a placeholder and assurance
of compliance with section 1902(a) of the Social Security Act; Form
Number: CMS-10367 (OMB: 0938-NEW); Frequency: Occasionally;
Affected Public: State, Local, or Tribal Governments; Number of
Respondents: 56; Total Annual Responses: 56; Total Annual Hours: 5.
(For policy questions regarding this collection contact Carla Ausby at
410-786-2153. For all other issues call 410-786-1326.)
To obtain copies of the supporting statement and any related forms
for the proposed paperwork collections referenced above, access CMS'
Web site at https://www.cms.hhs.gov/PaperworkReductionActof1995, or e-
mail your request, including your address, phone number, OMB number,
and CMS document identifier, to Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786-1326.
In commenting on the proposed information collections please
reference the document identifier or OMB control number. To be assured
consideration, comments and recommendations must be submitted in one of
the following ways by February 22, 2011:
1. Electronically. You may submit your comments electronically to
https://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number, Room C4-26-05, 7500 Security Boulevard, Baltimore,
Maryland 21244-1850.
Dated: December 17, 2010.
Martique Jones,
Director, Regulations Development Division-B, Office of Strategic
Operations and Regulatory Affairs.
[FR Doc. 2010-32197 Filed 12-22-10; 8:45 am]
BILLING CODE 4120-01-P
